Scarica l'app Stockscreener
12.10
4.80%
-0.61
Dopo l'orario di chiusura:
12.30
0.20
+1.65%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OCUL Giù?
Forum
Previsione
Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie
Ocular Therapeutix (NASDAQ:OCUL) Stock Price Down 5%Here's What Happened - MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) Earns Buy Rating from Analysts at Chardan Capital - MarketBeat
Goldman Sachs Group Inc. Has $4.27 Million Stock Position in Ocular Therapeutix, Inc. $OCUL - MarketBeat
Ocular Therapeutix, Inc. $OCUL Shares Sold by Woodline Partners LP - MarketBeat
Big Picture: Is Ocular Therapeutix Inc gaining market shareWeekly Investment Report & AI Driven Stock Movement Reports - خودرو بانک
Will Ocular Therapeutix Inc benefit from geopolitical trendsPortfolio Return Report & Trade Opportunity Analysis - khodrobank.com
Stop Loss: What makes Ocular Therapeutix Inc. stock attractive todayEarnings Growth Summary & Consistent Return Investment Signals - خودرو بانک
Can Ocular Therapeutix Inc stock outperform in a bear marketRate Hike & Daily Profit Maximizing Tips - خودرو بانک
Can Ocular Therapeutix Inc outperform in the next rally2025 Institutional Moves & Verified Entry Point Detection - خودرو بانک
Is Ocular Therapeutix Inc a defensive stockWeekly Investment Report & Low Drawdown Trading Strategies - khodrobank.com
Ocular Therapeutix's (OCUL) Investor Day to Spotlight AXPAXLI Program's Potential in Retinal Disease Treatment - Sahm
Breakouts Watch: Will Ocular Therapeutix Inc stock hit new highs in YEAR2025 Trading Recap & AI Based Trade Execution Alerts - khodrobank.com
Aug Retail: How much upside does Ocular Therapeutix Inc. have2025 Short Interest & Accurate Entry and Exit Point Alerts - khodrobank.com
Market Catalysts: Can Ocular Therapeutix Inc maintain its current growth rate2025 Institutional Moves & Low Drawdown Momentum Ideas - khodrobank.com
Patterns Watch: Is Ocular Therapeutix Inc a defensive stockMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - khodrobank.com
Levels Update: Is Ocular Therapeutix Inc forming bullish engulfing patternsJuly 2025 Reactions & Smart Allocation Stock Tips - khodrobank.com
Ocular Therapeutix (NASDAQ:OCUL) Coverage Initiated by Analysts at Chardan Capital - Defense World
Dow Update: Can Siyata Mobile Inc Equity Warrant navigate macro headwindsQuarterly Profit Report & Risk Controlled Stock Alerts - خودرو بانک
Geopolitics Watch: Whats Ocular Therapeutix Incs historical returnJuly 2025 Volume & Community Consensus Trade Signals - khodrobank.com
Aug Patterns: Can Ocular Therapeutix Inc outperform in the next rallyEarnings Trend Report & Precise Entry and Exit Recommendations - khodrobank.com
Hedge Fund Moves: Is Ocular Therapeutix Inc gaining market shareJuly 2025 Chart Watch & AI Powered Market Entry Ideas - khodrobank.com
Stop Loss: How is EBAY managing supply chain issuesJuly 2025 Movers & Consistent Return Strategy Ideas - خودرو بانک
CEO Moves: What are Ocular Therapeutix Inc.’s earnings expectationsGap Up & Low Risk High Reward Ideas - khodrobank.com
Chardan Capital Initiates Coverage of Ocular Therapeutix (OCUL) with Buy Recommendation - Nasdaq
Ocular Therapeutix (OCUL) Receives New Coverage with 'Buy' Rating and $21 PT | OCUL Stock News - GuruFocus
This Broadcom Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Chardan Capital Initiates Ocular Therapeutix at Buy With $21 Price Target - MarketScreener
Insider Trends: Can Ocular Therapeutix Inc. disrupt its industryMarket Risk Summary & Precise Swing Trade Alerts - khodrobank.com
Cubist Systematic Strategies LLC Acquires New Shares in Ocular Therapeutix, Inc. $OCUL - MarketBeat
Polar Asset Management Partners Inc. Lowers Stock Position in Ocular Therapeutix, Inc. $OCUL - MarketBeat
Ocular Therapeutix, Inc. $OCUL Shares Sold by Northern Trust Corp - MarketBeat
Analysts Set Ocular Therapeutix, Inc. (NASDAQ:OCUL) Price Target at $17.20 - MarketBeat
Panagora Asset Management Inc. Trims Stock Position in Ocular Therapeutix, Inc. $OCUL - MarketBeat
Adage Capital Partners GP L.L.C. Purchases 1,600,000 Shares of Ocular Therapeutix, Inc. $OCUL - MarketBeat
Ocular Hypertension Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Bausch + Lomb, Aerie Pharma, Santen Pharma, AbbVie (Allergan), Nicox, Kowa, Qlaris Bio, Noveome Bio - The Globe and Mail
Ocular Therapeutix gains amid takeover speculation - MSN
Ocular Therapeutix (NASDAQ:OCUL) Reaches New 12-Month HighHere's What Happened - MarketBeat
Ocular Therapeutix at Morgan Stanley Conference: Strategic Clinical Insights By Investing.com - Investing.com Canada
Ocular Therapeutix™ to Host Investor Day on September 30, 2025 | - GuruFocus
Ocular Therapeutix™ to Host Investor Day on September 30, 2025 - The Manila Times
Ocular Therapeutix: A High-Stakes Bet On Becoming The New Standard Of Care (NASDAQ:OCUL) - Seeking Alpha
Key deals this week: Ocular Therapeutix, CoreWeave, Air Lease, Cadence and more (AL:NYSE) - Seeking Alpha
Best data tools to analyze Ocular Therapeutix Inc. stockWeekly Market Summary & Target Return Focused Stock Picks - Newser
Is Ocular Therapeutix Inc. a candidate for recovery play2025 Key Lessons & AI Forecasted Entry and Exit Points - Newser
Can Ocular Therapeutix Inc. rally from current levelsEarnings Growth Summary & Growth-Oriented Investment Plans - Newser
Can Ocular Therapeutix Inc. disrupt its industryEarnings Summary Report & Real-Time Buy Zone Alerts - خودرو بانک
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Recommendation of “Buy” from Brokerages - Defense World
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):